These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5969030)

  • 1. Synthesis of 1-L-penicillamine-oxytocin, 1-D-penicillamine-oxytocin, and 1-deaminopenicillamine-oxytocin, potent inhibitors of the oxytocic response of oxytocin.
    Schulz H; Du Vigneaud V
    J Med Chem; 1966 Sep; 9(5):647-50. PubMed ID: 5969030
    [No Abstract]   [Full Text] [Related]  

  • 2. Some pharmacologic studies on 1-L-penicillamine-oxytocin and 1-deaminopenicillamine-oxytocin: two potent oxytocin inhibitors.
    Chan WY; Fear R; Du Vigneaud V
    Endocrinology; 1967 Dec; 81(6):1267-77. PubMed ID: 6064990
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of three oxytocin analogs related to (1-deaminopenicillamine)oxytocin possessing antioxytocic acitvity.
    Vavrek RJ; Ferger MF; Allen GA; Rich DH; Blomquist AT; Du Vigneaud V
    J Med Chem; 1972 Feb; 15(2):123-6. PubMed ID: 5008235
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of oxytocic responses to oxytocin in pregnant rats by (1-L-penicillamine)oxytocin and (1-beta-mercapto-beta, beta-diethylpropionic acid)oxytocin.
    Chan WY; Nestor JJ; Ferger MF; Du Vigneaud V
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):364-6. PubMed ID: 4834445
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of 1-L-penicillamine-oxytocin and 1-deaminopenicillamine-oxytocin to inhibit the uterine effect of oxytocin in rabbits in vivo.
    Fuchs AR; Lopes AC
    Endocrinology; 1970 Jan; 86(1):71-6. PubMed ID: 5409455
    [No Abstract]   [Full Text] [Related]  

  • 6. A pharmacologic analysis of the significance of the chemical functional groups of oxytocin to its oxytocic activity and on the effect of magnesium on the in vitro and in vivo oxytocic activity of neurohypophysial hormones.
    Chan WY; Kelley N
    J Pharmacol Exp Ther; 1967 Apr; 156(1):150-8. PubMed ID: 6023591
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and pharmacological activity of 4-d-glutamine-oxytocin, 5-d-asparagine-oxytocin, and 4-d-glutamine-5-d-asparagine-oxytocin.
    Dutta AS; Anand N; Kar K
    J Med Chem; 1966 Jul; 9(4):497-9. PubMed ID: 5968013
    [No Abstract]   [Full Text] [Related]  

  • 8. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S; Schwartz IL; Walter R
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis, pharmacological, conformational, and dynamic studies of the potent hormone antagonists [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin. Conformational and dynamic considerations in the design of antagonists.
    Hruby VJ; Mosberg HI; Hadley ME; Chan WY; Powell AM
    Int J Pept Protein Res; 1980 Nov; 16(5):372-81. PubMed ID: 7216613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of oxytocic drugs on the contractility the rat uterus and bioelectrical phenomena following beta receptor blockade].
    Urban J; Zasztowt O; Czekanowski R
    Ginekol Pol; 1969 Jun; 40(6):613-9. PubMed ID: 5806540
    [No Abstract]   [Full Text] [Related]  

  • 11. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of magnesium ion and oxytocin inhibitors on the uterotonic activity of oxytocin and prostaglandins E2 and F2ALPHA.
    Chan WY; Hruby VJ; Du Vigneaud V
    J Pharmacol Exp Ther; 1974 Jul; 190(1):77-87. PubMed ID: 4847314
    [No Abstract]   [Full Text] [Related]  

  • 13. The design of effective in vivo antagonists of rat uterus and milk ejection responses to oxytocin.
    Sawyer WH; Haldar J; Gazis D; Seto J; Bankowski K; Lowbridge J; Turan A; Manning M
    Endocrinology; 1980 Jan; 106(1):81-91. PubMed ID: 7349976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties.
    Yamanaka T; Hase S; Sakakibara S; Schwartz IL; Dubois BM; Walter R
    Mol Pharmacol; 1970 Sep; 6(5):474-80. PubMed ID: 5466703
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of adenosine triphosphate on the rat myometrium stimulated by oxytocic preparations].
    Lapiński Z
    Ginekol Pol; 1969; 40(4):353-62. PubMed ID: 5785305
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of adenosinetriphosphoric acid upon rat's myometrium stimulated by oxytocic preparations.
    Lapiński Z
    Pol Med J; 1970; 9(1):250-6. PubMed ID: 5437040
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and pharmacological properties of 9-decarboxamido-oxytocin.
    Branda LA; Du Vigneaud V
    J Med Chem; 1966 Mar; 9(2):169-72. PubMed ID: 5911792
    [No Abstract]   [Full Text] [Related]  

  • 19. [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor.
    Hruby VJ; Deb KK; Yamamoto DM; Hadley ME; Chan WY
    J Med Chem; 1979 Jan; 22(1):7-12. PubMed ID: 423185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Isoleucine-oxytocin and deamino-2-isoleucine-oxytocin: their synthesis and some of their pharmacologic activities.
    Branda LA; Hruby VJ; Du Vigneaud V
    Mol Pharmacol; 1967 May; 3(3):248-53. PubMed ID: 6068341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.